Over-the-counter availability of antibiotics together with poor access to diagnostics is recognised to promote antimicrobial resistance (AMR) including generation of drug-resistant tuberculosis (DR-TB). In accordance with the End TB Strategy target of ending TB epidemic by 2030, efforts to control DR-TB are ongoing in Eastern Mediterranean Region (EMR) countries, a number of which have well-established facilities for diagnostics, disease care and prevention as well as surveillance. These could serve as models for AMR control. The United Nation\u27s historic 2016 declaration recognises AMR as a threat to health, food production and development, and emphasises the need for global action. In view of this declaration, establishment of collabora...
Tuberculosis (TB) continues to pose a public-health threat to the people of the member states of the...
Many low- and middle-income countries facing high levels of antimicrobial resistance, and the associ...
Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet tuberculo...
AbstractObjective/backgroundOver-the-counter availability of antibiotics together with poor access t...
AbstractObjective/BackgroundThe objectives of this study were to highlight the key challenges and th...
Tuberculosis (TB) is a leading cause of death globally. TB had been considered conquered in Europe b...
Many low- and middle-income countries facing high levels of antimicrobial resistance, and the associ...
Adequate management of drug-resistant tuberculosis (TB), including multidrug- (MDR) and extensively ...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
• Multidrug-resistant tuberculosis (MDR TB) and other deadly infectious diseases com-monly occur in ...
Aim: The purpose of this viewpoint is to summarize the advantages and constraints of the tools and s...
AbstractThe 2015 represent the deadline for the global tuberculosis (TB) targets set through the Mil...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
According to the World Health Organization (WHO), 10.4 million people died of tuberculosis (TB) in 2...
AbstractTuberculosis (TB), the infectious disease caused by the bacterium Mycobacterium tuberculosis...
Tuberculosis (TB) continues to pose a public-health threat to the people of the member states of the...
Many low- and middle-income countries facing high levels of antimicrobial resistance, and the associ...
Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet tuberculo...
AbstractObjective/backgroundOver-the-counter availability of antibiotics together with poor access t...
AbstractObjective/BackgroundThe objectives of this study were to highlight the key challenges and th...
Tuberculosis (TB) is a leading cause of death globally. TB had been considered conquered in Europe b...
Many low- and middle-income countries facing high levels of antimicrobial resistance, and the associ...
Adequate management of drug-resistant tuberculosis (TB), including multidrug- (MDR) and extensively ...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
• Multidrug-resistant tuberculosis (MDR TB) and other deadly infectious diseases com-monly occur in ...
Aim: The purpose of this viewpoint is to summarize the advantages and constraints of the tools and s...
AbstractThe 2015 represent the deadline for the global tuberculosis (TB) targets set through the Mil...
The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This wil...
According to the World Health Organization (WHO), 10.4 million people died of tuberculosis (TB) in 2...
AbstractTuberculosis (TB), the infectious disease caused by the bacterium Mycobacterium tuberculosis...
Tuberculosis (TB) continues to pose a public-health threat to the people of the member states of the...
Many low- and middle-income countries facing high levels of antimicrobial resistance, and the associ...
Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet tuberculo...